Liver problems linked to Abbott Laboratories Inc.'s discontinued attention deficit drug Cylert and other generic versions make it too dangerous for the U.S. market, the Food and Drug Administration said on Monday.
foggyguy38650.3142824074thank you I need to know all about what is out there for my daughter.